StockWatch
·

Valiant Organics Ltd

BSE: 540145

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
305.32
+30.4%+94.0%
Expenditure
280.69
+36.7%+87.1%
Net Profit
17.15
-21.4%+206.5%
OPM %
12.83%
-5.15pp-0.63pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
-49.1448.97147.08245.19343.30Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

Valiant Organics Q1 FY27: consol PAT triples to ₹29.3 Cr as Pharma turns profitable

specialty chemicals · pharma segment · margin expansion

ResultsQ1 FY2712 Aug 20263 minMetals & Mining
Latest

Corporate Events

Board MeetingVALIANTORG
2026
5Nov

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing ↗
Board MeetingVALIANTORG
2026
29Sep

Board Meeting

The Company has initiated sending letters containing the web…

BSE Filing ↗
Board MeetingVALIANTORG
2026
12Aug

Board Meeting

The meeting of the Board of Directors of the Company is sche…

BSE Filing ↗
Board MeetingVALIANTORG
2026
16May

Board Meeting

The Nomination and Remuneration Committee (NRC) of the Board…

BSE Filing ↗
Board MeetingVALIANTORG
2024
13Nov

Board Meeting

Approval Of Financial Results For The Quarter And Half Year …

BSE Filing ↗
Board MeetingVALIANTORG
2024
13Aug

Board Meeting

Audited Standalone & Consolidated Financial results of the C…

BSE Filing ↗
Board MeetingVALIANTORG
2024
24May

Board Meeting

[Consider and approve The Audited Standalone & Consolidated …

BSE Filing ↗
Board MeetingVALIANTORG
2024
13Feb

Board Meeting

Consider and approve The Audited Standalone & Consolidated F…

BSE Filing ↗
Board MeetingVALIANTORG
2023
9Aug

Board Meeting

Consider and approve The Audited Standalone & Consolidated F…

BSE Filing ↗